Originally incorporated as “Fresenius Mafatlal Medicals Private Limited.” – Joint venture with Mafatlal Group
Name changed to “Fresenius Mafatlal Medicals Limited.”
Name Changed to Fresenius Kabi India Limited
Became subsidiary of Fresenius Kabi AG
Name Changed to Fresenius Kabi India Private Limited due to conversion from Limited to Private Limited Company
Fresenius Kabi grown its I.V. generics business and expanded into oncology drugs with the Dabur Pharma acquisition.
Fresenius Kabi acquired the transfusion technology company Fenwal and created a global leader in transfusion technology with a broad product portfolio for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.
2013
Manufacturing Unit of Goa Formulations Limited in Goa was acquired by Fresenius Kabi India Pvt Ltd.
Fresenius Kabi India Pvt Ltd launched 2 new divisions - EN Outside Market (Enteral Nutrition Products for Out Side Hospital Market) and Kabi Criticare (I.V.Drugs)
